INGN Q3 2021 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$172M

Q3 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$93M+25.3% YoY

Gross Profit

$48M51.2% margin

Operating Income

$6M6.8% margin

Net Income

$12M13.1% margin

EPS (Diluted)

$0.53

QoQ Revenue Growth

-8.3%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$9M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$513M

Total Liabilities

$122M

Stockholders' Equity

$391M

Cash & Equivalents

$242M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$93M	$74M	+25.3%
Gross Profit	$48M	$33M	+44.5%
Operating Income	$6M	-$2M	+423.1%
Net Income	$12M	-$2M	+816.5%

Geographic Segments

U S

$71M77%

Non Us

$22M23%